The average price target of $25.5 for Stoke Therapeutics, as determined by 8 analysts, implies an upside from the current price of $13.08. This indicates a positive short-term impact on the stock price, as the majority of analysts have a bullish outlook. The increase in the average price target from $14.50 to $25.5 further supports this positive sentiment.